Literature DB >> 1540583

A peptide model for the heparin binding site of antithrombin III.

A C Lellouch1, P T Lansbury.   

Abstract

A peptide model for the heparin binding site of antithrombin III (ATIII) was synthesized to elucidate the structural consequences of heparin binding. This peptide [ATIII(123-139)] and a sequence-permuted analogue (ATIII random) showed similar conformational behavior (as analyzed by circular dichroism spectroscopy) in aqueous and organic media. In the presence of heparin, however, the peptide ATIII(123-139) assumed a stable conformation, whereas peptide ATIII random did not. Complex formation was saturable and sensitive to salt. The ATIII(123-139)-heparin complex contained beta-structure, rather than helical structure. This finding is incompatible with current models of heparin binding and suggests that heparin binding may induce nonnative structures at the binding site which could, in turn, lead to activation of ATIII. The peptide ATIII(123-139) was able to inhibit the binding of ATIII by heparin, consistent with the notion that this peptide may be a model for the heparin binding site.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540583     DOI: 10.1021/bi00123a010

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Low molecular weight protamine (LMWP) as nontoxic heparin/low molecular weight heparin antidote (I): preparation and characterization.

Authors:  L C Chang; H F Lee; Z Yang; V C Yang
Journal:  AAPS PharmSci       Date:  2001

2.  A peptide-model for the heparin-binding property of pseudorabies virus glycoprotein III.

Authors:  D Sawitzky; A Voigt; K O Habermehl
Journal:  Med Microbiol Immunol       Date:  1993-12       Impact factor: 3.402

3.  Interaction of heparin with synthetic antithrombin III peptide analogues.

Authors:  J Bae; U R Desai; A Pervin; E E Caldwell; J M Weiler; R J Linhardt
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

4.  Cloning of the full-length cDNA of porcine antithrombin III and comparison with its human homolog.

Authors:  Younan Chen; Weidong Tan; Shengfang Qin; Jie Zhang; Hong Bu; Youping Li; Yanrong Lu; Jingqiu Cheng
Journal:  Comp Med       Date:  2009-08       Impact factor: 0.982

5.  Heparin binding domain peptides of antithrombin III: analysis by isothermal titration calorimetry and circular dichroism spectroscopy.

Authors:  R Tyler-Cross; M Sobel; D Marques; R B Harris
Journal:  Protein Sci       Date:  1994-04       Impact factor: 6.725

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.